Home » Newsletters » BioWorld Asia

BioWorld Asia

June 3, 1998

View Archived Issues

Canadian Start-Ups Increase With Surge In Venture Capital

Exiqon Spins Off Firm For Drugs That Mimic Nucleic Acids

Australia Earmarking A$20M To Boost Biotech Industry

EU Renews Efforts To Adopt Orphan Drug Regulations

Karo Bio Extends Alliance With UC Collaborators

Former Pharma Execs Bringing European Biotech To Japan

Progen Shares Surge, Retreat As Cancer Drug Enters Phase I

Inex Mouse Data Promising On Cancer Gene Therapy

Interferon Gene Therapy Beats HIV In Lab Studies

EU Explains 'Exceptional' Approval For Ares' Rebif

Other News to Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...